Poor
Poorly Aligned
Patient Risk:
Moderate
Summary
The claims include several label-supported facts, but many food-related risk comparisons, mechanisms, OTC directions, claims about other medicines, and monitoring instructions are not supported by the supplied prescribing information. Some supported claims are also stated more broadly than the label supports.
Category Scores
Accurate Statements
For mild to moderate pain, the label gives ibuprofen 400 mg every 4 to 6 hours as necessary.
Dosage and Administration specifies 400 mg every 4 to 6 hours as necessary for relief of mild to moderate pain.
If gastrointestinal complaints occur, ibuprofen should be administered with meals or milk.
Dosage and Administration directly gives this instruction.
Nausea, heartburn, ulcers, gastrointestinal hemorrhage, melena, and gastritis are reported gastrointestinal adverse reactions.
These reactions are listed in Adverse Reactions.
Ibuprofen and warfarin-type anticoagulants can together increase the risk of serious gastrointestinal bleeding.
Drug Interactions states that warfarin and NSAIDs have synergistic effects on GI bleeding risk and advises caution with anticoagulants.
Use of ibuprofen during late pregnancy should be avoided.
Pregnancy states that use during late pregnancy should be avoided because of NSAID effects on the fetal cardiovascular system.
Caution should be exercised when treating patients 65 years and older.
Geriatric Use advises caution in elderly patients, defined as 65 years and older.
Bronchospasm is a reported adverse reaction associated with ibuprofen.
Adverse Reactions lists bronchospasm among allergic reactions with a probable causal relationship.
Black stools can be associated with gastrointestinal bleeding during ibuprofen use.
Adverse Reactions lists melena and gastrointestinal hemorrhage.
Unsupported Statements
Food or milk reduces stomach irritation, nausea, or ulcers compared with taking ibuprofen on an empty stomach; taking it with food is safer or provides the best protection; meals containing fat or protein are best; or empty-stomach use causes higher rates of gastritis or bleeding.
The label advises meals or milk if gastrointestinal complaints occur, but does not compare outcomes by food status or specify meal composition or protective benefit.
Food buffers direct contact with the stomach lining; food slows absorption slightly; COX inhibition impairs protective mucus or increases stomach acid; or empty-stomach use has a high stomach risk.
These mechanisms and risk characterizations are not stated in the supplied sections.
Up to 15–30% of long-term users develop ulcers without protective measures.
The label lists ulcers as adverse reactions but provides no such incidence estimate.
Ibuprofen should be taken immediately after a meal or snack, or a single empty-stomach dose is usually fine for most healthy adults.
The label gives neither the timing instruction nor an assessment of single-dose empty-stomach use.
Lying down within 30 minutes can cause reflux; a full glass of water should be taken; or calcium carbonate antacids can help after ibuprofen-related heartburn or pain.
These administration and treatment instructions are not provided in the supplied sections.
The standard OTC dose is 200–400 mg every 4–6 hours, or the maximum OTC dose is 1,200 mg per day.
The supplied prescription-label section specifies 400 mg every 4–6 hours for mild to moderate pain and a maximum total daily dose of 3,200 mg; it does not provide OTC directions or an OTC maximum.
Repeated doses increase risk when taken without food, or use for more than 10 days requires monitoring regardless of meals.
The supplied sections do not compare food status or dose frequency for risk and do not specify a 10-day monitoring requirement.
People with ulcers, GERD, kidney disease, or asthma face higher risks even when taking ibuprofen with meals; people with asthma specifically face increased risk of bronchospasm.
The supplied sections do not establish these population-specific risk comparisons or a meal effect. Bronchospasm is listed as an adverse reaction but is not specifically linked to asthma in these sections.
People taking steroids face higher risks even when taking ibuprofen with meals.
The supplied Drug Interactions section does not discuss corticosteroids.
Pregnant individuals should use alternatives such as acetaminophen, and people over 65 should use alternatives such as acetaminophen.
The label advises avoiding use during late pregnancy and exercising caution in patients 65 and older, but does not recommend acetaminophen or other alternatives.
Aspirin has the highest stomach risk on an empty stomach; food is least protective for aspirin; or acetaminophen and naproxen have the stated stomach-risk, food-effect, duration, or anti-inflammatory characteristics.
The supplied sections do not provide these comparisons or information about acetaminophen or naproxen. The label's comparison of gastrointestinal complaints with aspirin and indomethacin does not rank empty-stomach risk.
Topical NSAIDs are an alternative for sensitive stomachs; acetaminophen has no gastrointestinal risk or avoids gastrointestinal issues entirely; or swelling can signal ibuprofen-associated bleeding.
These claims are not supported by the supplied sections. Edema and fluid retention are listed adverse reactions, but the label does not link them to bleeding.
Severe abdominal pain or vomiting blood can signal bleeding associated with ibuprofen use.
The label separately lists abdominal pain, nausea and vomiting, and gastrointestinal hemorrhage, but does not identify these specific symptoms as signs of bleeding.
Ibuprofen inhibits COX enzymes.
The label attributes certain interactions to inhibition of renal prostaglandin synthesis but does not identify COX enzymes in the supplied sections.
Contradictions
Important Omissions
The label's food instruction is conditional: administer ibuprofen with meals or milk if gastrointestinal complaints occur. It does not characterize this as proven protection against ulcers or other serious gastrointestinal events.
Importance:
Moderate
The label directs use of the lowest effective dose for the shortest duration consistent with the patient's treatment goals.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
The claims may overstate the protection provided by food and include unsupported medication comparisons, risk statements, and advice for special populations. The label-supported caution about meals or milk applies when gastrointestinal complaints occur and does not establish that food prevents serious gastrointestinal adverse events.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Poorly Aligned
Primary Issue
Many specific food-related risk claims, OTC directions, comparisons with other drugs, and population-specific recommendations are not supported by the supplied prescribing information.
Suggested Improvement
Limit statements to the supplied label: use the lowest effective dose for the shortest duration, administer with meals or milk if gastrointestinal complaints occur, and accurately distinguish the label's cautions and listed adverse reactions from unsupported comparisons or mechanisms.